Torrent Pharmaceuticals Statistics

Total Valuation

Torrent Pharmaceuticals has a market cap or net worth of INR 1.15 trillion. The enterprise value is 1.17 trillion.

Market Cap	1.15T
Enterprise Value	1.17T

Important Dates

The next estimated earnings date is Monday, January 27, 2025.

Earnings Date	Jan 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.02%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	105.62M

Valuation Ratios

The trailing PE ratio is 63.87.

PE Ratio	63.87
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	40.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 32.74, with an EV/FCF ratio of 39.94.

EV / Earnings	64.92
EV / Sales	10.42
EV / EBITDA	32.74
EV / EBIT	41.86
EV / FCF	39.94

Financial Position

The company has a current ratio of 1.21, with a Debt / Equity ratio of 0.42.

Current Ratio	1.21
Quick Ratio	0.62
Debt / Equity	0.42
Debt / EBITDA	0.87
Debt / FCF	1.07
Interest Coverage	9.39

Financial Efficiency

Return on equity (ROE) is 25.37% and return on invested capital (ROIC) is 16.01%.

Return on Equity (ROE)	25.37%
Return on Assets (ROA)	11.71%
Return on Capital (ROIC)	16.01%
Revenue Per Employee	7.14M
Profits Per Employee	1.15M
Employee Count	15,718
Asset Turnover	0.75
Inventory Turnover	1.22

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +52.96% in the last 52 weeks. The beta is 0.25, so Torrent Pharmaceuticals's price volatility has been lower than the market average.

Beta (5Y)	0.25
52-Week Price Change	+52.96%
50-Day Moving Average	3,295.09
200-Day Moving Average	3,049.13
Relative Strength Index (RSI)	57.73
Average Volume (20 Days)	346,813

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Torrent Pharmaceuticals had revenue of INR 112.24 billion and earned 18.02 billion in profits. Earnings per share was 53.25.

Revenue	112.24B
Gross Profit	84.76B
Operating Income	27.95B
Pretax Income	25.79B
Net Income	18.02B
EBITDA	35.51B
EBIT	27.95B
Earnings Per Share (EPS)	53.25

Full Income Statement

Balance Sheet

The company has 12.35 billion in cash and 31.26 billion in debt, giving a net cash position of -18.91 billion.

Cash & Cash Equivalents	12.35B
Total Debt	31.26B
Net Cash	-18.91B
Net Cash Per Share	n/a
Equity (Book Value)	75.04B
Book Value Per Share	221.48
Working Capital	10.32B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 34.09 billion and capital expenditures -4.80 billion, giving a free cash flow of 29.29 billion.

Operating Cash Flow	34.09B
Capital Expenditures	-4.80B
Free Cash Flow	29.29B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.51%, with operating and profit margins of 24.91% and 16.06%.

Gross Margin	75.51%
Operating Margin	24.91%
Pretax Margin	22.98%
Profit Margin	16.06%
EBITDA Margin	31.64%
EBIT Margin	24.91%
FCF Margin	26.10%

Dividends & Yields

Torrent Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	27.27%
Years of Dividend Growth	n/a
Payout Ratio	52.56%
Buyback Yield	-0.02%
Shareholder Yield	-0.02%
Earnings Yield	1.57%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on July 8, 2022. It was a forward split with a ratio of 2.

Last Split Date	Jul 8, 2022
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a